Tci Gene (ROCO:6879) Ending Cash Position : NT$696.0 Mil (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Tci Gene Ending Cash Position?

Tci Gene's Ending Cash Position for the quarter that ended in Dec. 2023 was NT$696.0 Mil.

Tci Gene's quarterly Ending Cash Position declined from Dec. 2022 (NT$932.7 Mil) to Jun. 2023 (NT$823.9 Mil) and declined from Jun. 2023 (NT$823.9 Mil) to Dec. 2023 (NT$696.0 Mil).

Tci Gene's annual Ending Cash Position increased from Dec. 2021 (NT$326.2 Mil) to Dec. 2022 (NT$932.7 Mil) but then declined from Dec. 2022 (NT$932.7 Mil) to Dec. 2023 (NT$696.0 Mil).

Tci Gene Ending Cash Position Historical Data

The historical data trend for Tci Gene's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tci Gene Ending Cash Position Chart

Tci Gene Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

151.75

177.57

326.19

932.74

696.05

Tci Gene Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Ending Cash Position	Get a 7-Day Free Trial				326.19	900.41	932.74	823.93	696.05

Tci Gene Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Tci Gene's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	932.738	+	-236.692
	=	696.0

Tci Gene's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	823.931	+	-127.885
	=	696.0

Tci Gene Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Tci Gene's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Tci Gene (ROCO:6879) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tci Gene Inc (ROCO:6879) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 185-1, Gangqian Rd, 10th FLoor, Neihu District, Taipei, TWN

Website

https://www.genext.me

Tci Gene Inc provides precision preventive medicines in Taiwan. It is the first to introduce the concept of precision preventive medicine with Predict prediction, Prevent prevention, and Personal Treatment personalized health management measures.

Tci Gene (ROCO:6879) Headlines

No Headlines